Now FDA Approved
At the Sanofi Foundation for North America our focus on helping children, especially those in need, is a platform that cuts across all Sanofi businesses and positively impacts young, sometimes fragile lives. Whether targeting the medically underserved, those born prematurely, or those struggling with cancer, we continue to support those championing such noble causes.
Sanofi US is voluntarily recalling all Auvi-Q® (epinephrine injection, USP). The recall involves all Auvi-Q® currently on the market and includes both the 0.15 mg and 0.3 mg strengths for hospitals, retailers and consumers.
Last update: June 08, 2016